GREGORY RAU: Open Payments
NPI 1528006038 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,887 in 276 payments from 22 companies in 2025. Trend: 2023 $63,549 · 2024 $54,607 · 2025 $57,887
Speaker / faculty: $44,342Consulting: $6,303Food & beverage: $4,113Travel & lodging: $3,128
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 46 | $16,904 |
| Lilly USA, LLC | 28 | $14,703 |
| ABBVIE INC. | 26 | $7,945 |
| Amgen Inc. | 17 | $6,659 |
| Galderma Laboratories, L.P. | 27 | $5,534 |
| PFIZER INC. | 25 | $3,796 |
| Journey Medical Corporation | 12 | $591 |
| Almirall LLC | 17 | $303 |
| E.R. Squibb & Sons, L.L.C. | 4 | $263 |
| UCB, Inc. | 17 | $227 |
Products named: ADBRY, ANZUPGO, RINVOQ, NEMLUVIO, CIBINQO, TALTZ, Otezla, Seysara.
Industry payments across CT — which companies pay providers there.
